Sex-specific prevalence and factors associated with osteoporosis among older people living with HIV under long-term virological suppression in western China: A retrospective cross-sectional study
This retrospective cross-sectional study of 750 older, virologically suppressed people living with HIV in western China reveals a high overall osteoporosis prevalence (39.73%) with significantly higher rates in women, identifying shared risk factors like advanced age and inadequate physical activity alongside distinct sex-specific correlates such as TDF-containing regimens for men and menopause for women.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For decades, the narrative around HIV infection was defined by urgency and survival. With the advent of powerful combination therapies, the virus has been transformed from a fatal diagnosis into a manageable chronic condition. People living with HIV now grow old, joining the general population in navigating the natural challenges of aging. Yet, as these individuals age, they face a specific, silent threat that often goes unnoticed until a bone breaks. This threat is osteoporosis, a condition where bones become porous and brittle, losing their strength much like a wooden beam that has been slowly hollowed out by time and weather. While everyone loses some bone density as they get older, the process can be accelerated by chronic inflammation and long-term medication use. Understanding how this happens in people with HIV is crucial, not just for preventing fractures, but for ensuring that the extra years of life gained through treatment are lived with full mobility and independence.
A team of researchers in western China recently turned their attention to this exact problem, focusing on a group of 750 older adults living with HIV who had successfully suppressed the virus with medication for at least six months. These individuals, all aged 50 or older, were gathered from a medical center in Chongqing. The researchers wanted to know two things: how common osteoporosis was in this specific group, and whether the factors causing it were different for men and women. To find out, they reviewed the patients' medical records and looked at the results of bone density scans, a standard test that measures how much mineral is packed into the bones. They then compared the data between the men and the women to see if the story of bone loss played out differently for each sex.
The results revealed a stark reality. Nearly 40 percent of the entire group suffered from osteoporosis, a rate significantly higher than what is typically seen in the general population of older adults. However, the burden was not shared equally. The condition was far more prevalent among the women, affecting nearly 60 percent of them, compared to just over 28 percent of the men. This gap highlights that while the virus and its treatment affect everyone, the biological pathways leading to bone loss diverge sharply between the sexes. The study confirmed that age was a universal risk factor; as people got older, their risk of brittle bones increased regardless of gender. But beyond age, the specific triggers for bone loss told two very different stories.
For the women in the study, the risk of osteoporosis was tightly linked to the natural transition of menopause. Almost all the female participants had passed through menopause, a time when the body stops producing estrogen, a hormone that helps protect bone density. When this protection fades, the chronic inflammation caused by HIV appears to speed up bone loss even further. The researchers also found that for women, the length of time they had lived with the virus mattered; those infected for five years or more faced higher risks. Interestingly, for this group of women, the specific type of medication they took or their use of steroid drugs did not show a strong independent link to bone loss in the statistical analysis, suggesting that the hormonal shift of menopause was the dominant force driving their bone health issues.
The story for the men was different. While they did not face the sudden hormonal drop of menopause, their bone health was heavily influenced by their lifestyle and the specific medications they took. The study identified that men living in rural areas, those who did not engage in regular physical activity, and those who had used steroid medications for long periods were at significantly higher risk. Perhaps most notably, the researchers found a clear link between a specific class of HIV medication and bone damage, but this link appeared only in men. This medication, which contains a compound known to affect how the kidneys handle calcium, seemed to strip bone strength from the male participants specifically. For men, low levels of calcium in the blood also emerged as a distinct warning sign, compounding the risks posed by their treatment and environment.
These findings suggest that a single approach to bone health cannot work for everyone living with HIV. The data indicates that for older women, the focus should be on monitoring the effects of menopause and the duration of infection, while for men, the priority lies in managing medication choices, ensuring adequate calcium levels, and encouraging physical movement. The researchers noted that many of these patients lived in rural settings where access to sunlight and nutritious food might be limited, adding another layer of difficulty to maintaining strong bones. By recognizing these distinct patterns, doctors can move away from a one-size-fits-all strategy. Instead, they can tailor their advice and screening to the specific needs of men and women, ensuring that the extra years of life granted by modern medicine are supported by a foundation of strong, healthy bones.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.